CBiPES
Appearance
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H19N3O2S |
Molar mass | 377.459 g/mol g·mol−1 |
3D model (JSmol) | |
| |
|
CBiPES is a drug used in scientific research that acts as a selective positive allosteric modulator for the metabotropic glutamate receptor group II subtype mGluR2. It has potentially antipsychotic effects in animal models, and is used for researching the role of mGluR2 receptors in schizophrenia and related disorders.[1][2][3]
References
- ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 15717213, please use {{cite journal}} with
|pmid=15717213
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 19951716, please use {{cite journal}} with
|pmid=19951716
instead. - ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 22659090, please use {{cite journal}} with
|pmid=22659090
instead.